ArticleQuantitative imaging in medicine and surgery2026
Deep learning-based independent lymph node segmentation in esophageal cancer: a precise and efficient approach for radiotherapy planning.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Esophageal cancer (EC) is among the most commonly diagnosed malignancies and ranks as the seventh leading cause of cancer-related mortality globally. Radiotherapy (RT) plays a key role in the management of EC by controlling local recurrence and improving survival outcomes. However, in current clinical practice, the delineation of lymph node (LN) clinical target volumes (CTVs) for RT remains time-consuming and labour-intensive. Deep learning-based auto-segmentation (DLBAS), as the fourth generation of this technology, offers superior results in medical image segmentation. The purpose of this study was to train and validate DLBAS models for the segmentation of distinct LN CTVs in EC, with the aim of supporting and streamlining the delineation process. Methods: Contrast-enhanced computed tomography (CT) scans were acquired from EC patients between October 2013 and December 2018, within 2 weeks prior to surgery. Two experienced radiation oncologists manually delineated LN CTVs, including stations 101, 104, 105, 106, 107, 108 and 109. We developed DLBAS models based on the no-new-U-Net (nnU-Net) and quantitatively evaluated their segmentation performance using metrics such as the dice similarity coefficient (DSC) and the 95% Hausdorff distance (95HD). To assess clinical utility, another two radiation oncologists scored the automated segmentations in the test sets. Additionally, the time required for manual versus automated segmentation was recorded. Results: A total of 364 patients with 1,131 LN CTVs were included in this study. The DLBAS models achieved a mean DSC ranging from 0.71 to 0.79 for all LN CTV stations. The majority of automated segmentations received a score of ≥2 (indicating minimal or no correction required), accounting for 89.8% of the total cases, and none of the structures received a score of 0 (unusable). Furthermore, the DLBAS model significantly reduced the contouring time, decreasing the average time per LN CTV from 257 seconds to 79 seconds compared to manual segmentation. Conclusions: The proposed DLBAS model effectively improves both the efficiency and accuracy of LN CTV segmentation. These findings demonstrate its suitability for clinical application and highlight its promise for facilitating CT-guided adaptive radiation therapy in EC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.